FDA Authorizes Pharmacists to Prescribe Paxlovid
The FDA has granted state-licensed pharmacists the power to prescribe Paxlovid (nirmatrelvir and ritonavir) to eligible patients, with certain limitations.
Category: Industry & Regulatory News
Industry & Regulatory News
Latest
Industry & Regulatory News
Latest
GOLD 2022 Recommendations for COPD
The GOLD 2022 report updates evidence for blood eosinophil counts as biomarker in subset of patients with COPD.
Industry & Regulatory News
Latest
Dayton Children’s Hospital Contracts Medline as Laboratory Prime Vendor
Medline has been selected as Dayton Children’s Hospital’s laboratory prime vendor, entering into a multi-year agreement.
Association News
Latest
World No Tobacco Day: The Environmental Impact of Smoking
On World No Tobacco Day, May 31, international lung health groups are raising concerns over Big Tobacco's impact on environmental health and ultimately lung health.
Business News
Latest
Vitalograph Marks 21st Year as Clinical Trials Service Provider
Vitalograph is celebrating 21 years of empowering respiratory research through clinical trials services, with international team members fundraising for local respiratory charities to mark the milestone.
FDA Approvals
Latest
FDA Expands Authorization of Pfizer COVID Booster to Kids 5-through-11
Children age 5-through-11 are now authorized to receive the Pfizer COVID booster at least five months after completion of their primary two-dose series of the Pfizer vaccine.
Recalls & Advisories
Latest
Philips Provides Update on Medical Device Reports Linked to Recall
Philips responds to reports of an increase in medical device reports related to the company's respiratory device recall.